Zobrazeno 1 - 10
of 50
pro vyhledávání: '"O. M. Moiseev"'
Autor:
V. E. Uspenskiy, B. K. Salavatov, A. S. Pischugin, D. S. Tolpygin, A. B. Malashicheva, D. A. Zverev, O. M. Moiseev, M. L. Gordeev
Publikováno v:
Russian Journal for Personalized Medicine. 2:89-100
Autor:
V. E. Uspenskiy, V. L. Saprankov, V. I. Mazin, D. G. Zavarzina, A. B. Malashicheva, O. B. Irtyuga, O. M. Moiseeva, M. L. Gordeev
Publikováno v:
Российский кардиологический журнал, Vol 28, Iss 11 (2023)
Aim. To assess the association between pathological ascending aortic (AA) wall changes and its planimetric characteristics in non-syndromic non-familial (sporadic) aneurysm and dilation of the AA.Material and methods. The study included 174 patients
Externí odkaz:
https://doaj.org/article/34cb0d14cda941939849175f4aca5dd0
Autor:
S. V. Mayrina, I. A. Makarov, L. B. Mitrofanova, M. S. Vonsky, A. L. Runov, K. A. Papko, O. M. Moiseeva
Publikováno v:
Российский кардиологический журнал, Vol 28, Iss 11 (2023)
Aim. To characterize the clinical manifestations and myocardial morphological changes in patients with cardiovascular complications of post-Covid syndrome.Material and methods. A total of 38 patients (Group I) with cardiac symptoms in the post-COVID-
Externí odkaz:
https://doaj.org/article/b4c65d1e1a914d328ebb0c940953248d
Publikováno v:
Российский кардиологический журнал, Vol 28, Iss 9 (2023)
Aim. To compare cardiac magnetic resonance imaging (MRI) parameters with known prognosis determinants in patients with pulmonary hypertension (PH).Material and methods. This prospective single-center study included 60 patients with PH aged 21-72 year
Externí odkaz:
https://doaj.org/article/c17781924d6a4745a9c4f55560a62365
Autor:
S. V. Mairina, D. V. Ryzhkova, L. B. Mitrofanova, A. V. Ryzhkov, P. M. Murtazalieva, O. M. Moiseeva
Publikováno v:
Российский кардиологический журнал, Vol 28, Iss 5 (2023)
Aim. To analyze clinical and paraclinical data in patients with documented cardiac sarcoidosis, outlining the key points of diagnosis and selection of the optimal treatment.Material and methods. For the period from 2016 to 2021, 63 patients (50,4±14
Externí odkaz:
https://doaj.org/article/3c76bf2eb682473cac7222a7baa30d9b
Autor:
G. P. Arutyunov, F. N. Paleev, E. I. Tarlovskaya, O. M. Moiseeva, A. G. Arutyunov, N. A. Koziolova, A. I. Chesnikova, A. P. Rebrov, I. I. Shaposhnik, M. M. Petrova, N. Yu. Grigorieva, I. V. Fomin, Ya. A. Orlova, S. V. Malchikova, L. Yu. Koroleva, V. P. Nosov, S. A. Ayvazyan, O. V. Zairatyants, V. E. Sinitsyn, Yu. A. Vasyuk, G. E. Gendlin, D. O. Dragunov, A. V. Sokolova, O. B. Irtyuga
Publikováno v:
Российский кардиологический журнал, Vol 28, Iss 3 (2023)
Russian Society of Cardiology (RSC)With the participation of the Eurasian Association of Therapists, the Russian Scientific Medical Society of Therapists (RNMOT), the Russian Society of Pathologists, the Russian Society of Radiologists and Radiologis
Externí odkaz:
https://doaj.org/article/6196fbd87aab4d62be86bf2177857ab9
Publikováno v:
Российский кардиологический журнал, Vol 28, Iss 2 (2023)
In managing care for patients with rare, rapidly progressive pathologies such as pulmonary hypertension (PH) and chronic thromboembolic hypertension (CTEPH), early diagnosis and speed of routing are of particular importance. Reducing the time spent o
Externí odkaz:
https://doaj.org/article/ce29606ec6064d34907c0602e7dcc14c
Autor:
O. M. Moiseeva
Publikováno v:
Российский кардиологический журнал, Vol 27, Iss 3S (2022)
Externí odkaz:
https://doaj.org/article/9de37a2dbdf8415cbfeae09bd3690ed2
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 17, Iss 2, Pp 278-285 (2021)
This review presents an analysis of recent publications on the principles of diagnosis and management of patients with chronic thromboembolic pulmonary hypertension (CTEPH). The authors emphasize the importance of patient's operability assessment reg
Externí odkaz:
https://doaj.org/article/ff50cdbd8be540a793a89ce9f4fd2393
Autor:
M. A. Simakova, O. M. Moiseeva
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 16, Iss 2, Pp 317-323 (2020)
This narrative review describes and appraises some relatively new studies investigating the efficacy and safety profile of soluble guanylate cyclase stimulator riociguat in patients suffering from pulmonary arterial hypertension (PAH) and chronic thr
Externí odkaz:
https://doaj.org/article/18ec3b397a184d2bbd9e12894a5d4774